K2 Principal Fund’s Hims & Hers Health HIMS Stock Holding History

K2 Principal Fund’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-20,000	Closed	-$591K	–	323
2025 Q1	$591K	Buy	+20,000	New	+$743K	0.08%	185

Other funds holding HIMS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SIM

SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return

K2 Principal Fund's HIMS Position: Q4 2020 in Review

K2 Principal Fund sold out of Hims & Hers Health (HIMS) in Q4 2020, closing a stake of 378,503 shares — an estimated $4.45M sold.

K2 Principal Fund first reported a position in HIMS in Q1 2020 and held it in 3 quarters. The position peaked at $4.45M in Q3 2020. 42 funds tracked by Wall St. Rank hold HIMS as of Q4 2020.

K2 Principal Fund reported no remaining Hims & Hers Health position as of Q4 2020 after selling out during the quarter.
K2 Principal Fund sold 378,503 Hims & Hers Health shares in Q4 2020, an estimated $4.45M.
K2 Principal Fund first reported a position in Hims & Hers Health in Q1 2020 and held it in 3 quarters.
K2 Principal Fund's Hims & Hers Health position peaked at $4.45M in Q3 2020.
42 funds tracked by Wall St. Rank held Hims & Hers Health as of Q4 2020.

Based on K2 Principal Fund's 13F filing for Q4 2020, filed 12 Feb 2021.